SAN DIEGO � October 3, 2011 (Investorideas.com newswire) – Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has been awarded a $6.8 million contract from the Defense Advanced Research Projects Agency (DARPA) to develop a therapeutic device to reduce the incidence ...
The post Biotech/Medical Technology Stock News; Aethlon Medical (OTCBB: AEMD) Receives Government Contract Award from DARPA appeared first on Your Story.